» Articles » PMID: 11157697

Endothelial Dysfunction and Oxidative Stress During Estrogen Deficiency in Spontaneously Hypertensive Rats

Overview
Journal Circulation
Date 2001 Feb 7
PMID 11157697
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Postmenopausal estrogen deficiency is associated with an increased cardiovascular risk, hypertension, and oxidative stress. Angiotensin type 1 (AT(1)) receptor regulation is involved in the pathogenesis of atherosclerosis. To characterize vascular function, oxidative stress, and AT(1) receptor regulation during estrogen deficiency, ovariectomized spontaneously hypertensive rats (SHR) were investigated in comparison with sham-operated animals and with ovariectomized rats receiving estrogen replacement therapy with 17beta-estradiol.

Methods And Results: Arterial blood pressure was similar in all 3 groups investigated. Five weeks after ovariectomy, endothelial dysfunction in aortic rings was observed, which was reversed by estrogen replacement therapy. Estrogen deficiency led to an enhanced vasoconstriction by angiotensin II. Vascular superoxide production was significantly increased compared with that in sham-operated rats, as measured by lucigenin chemiluminescence assays. Estrogen substitution normalized the production of free radicals in the vessel wall. Vascular AT(1) receptor expression was significantly upregulated by estrogen deficiency, as shown by quantitative reverse transcription-polymerase chain reaction, whereas endothelial NO synthase mRNA expression and NO release were unchanged. Five-week treatment of the animals with the AT(1) receptor antagonist irbesartan prevented endothelial dysfunction in ovariectomized rats and normalized the vascular production of free radicals.

Conclusions: In SHR, estrogen deficiency leads to increased vascular free radical production and enhanced angiotensin II-induced vasoconstriction via increased vascular AT(1) receptor expression, resulting in endothelial dysfunction. Estrogen replacement therapy and AT(1) receptor antagonism prevent these pathological changes. Therefore, estrogen deficiency-induced AT(1) receptor overexpression and oxidative stress may play an important role in cardiovascular diseases associated with menopause.

Citing Articles

A mini-review of the evidence for cerebrovascular changes following gender-affirming hormone replacement therapy and a call for increased focus on cerebrovascular transgender health.

Wright M, Murphy K Front Hum Neurosci. 2023; 17:1303871.

PMID: 38077183 PMC: 10702528. DOI: 10.3389/fnhum.2023.1303871.


Hypertension after the Menopause: What Can We Learn from Experimental Studies?.

Pitha J, Vaneckova I, Zicha J Physiol Res. 2023; 72(Suppl 2):S91-S112.

PMID: 37565415 PMC: 10660576. DOI: 10.33549/physiolres.935151.


Sex differences in blood pressure regulation and hypertension: renal, hemodynamic, and hormonal mechanisms.

Drury E, Wu J, Gigliotti J, Le T Physiol Rev. 2023; 104(1):199-251.

PMID: 37477622 PMC: 11281816. DOI: 10.1152/physrev.00041.2022.


Noninvasive Monitoring of Blood Pressure and Heart Rate during Estrous Cycle Phases in Normotensive Wistar-Kyoto and Spontaneously Hypertensive Female Rats.

Ayala-Mendez G, Calderon V, Zuniga-Pimentel T, Rivera-Cerecedo C J Am Assoc Lab Anim Sci. 2023; 62(3):267-273.

PMID: 37130700 PMC: 10230531. DOI: 10.30802/AALAS-JAALAS-22-000081.


Association between raised blood pressure and elevated serum liver enzymes among active-duty Royal Thai Army personnel in Thailand.

Sakboonyarat B, Poovieng J, Lertsakulbunlue S, Jongcherdchootrakul K, Srisawat P, Mungthin M BMC Cardiovasc Disord. 2023; 23(1):143.

PMID: 36944947 PMC: 10029162. DOI: 10.1186/s12872-023-03181-3.